MiMedx
-
Hospitals
MiMedx Provides Update On Key Clinical Trials
MARIETTA, Ga., Aug. 30, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Biologics
MiMedx To Attend The Morgan Stanley Global Healthcare Conference
MARIETTA, Ga., Aug. 30, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected…
Read More » -
Hospitals
MiMedx Awarded Six New U.S. Patents with Five Awarded for its Amniotic Membrane Allografts and One Awarded for its CollaFix™ Technology
MARIETTA, Ga., Aug. 29, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Biologics
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
MARIETTA, Ga., July 25, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue…
Read More » -
Biologics
MiMedx Adds New Executive
MARIETTA, Ga., July 7, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected…
Read More » -
Hospitals
MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims
MARIETTA, Ga., June 21, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic…
Read More » -
Biologics
MiMedx Comments on Flawed Osiris Data Review
MARIETTA, Ga., May 3, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Financial
MiMedx Announces First Quarter of 2016 Revenue Results
MARIETTA, Ga., April 10, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected…
Read More » -
Biologics
MiMedx To Present At The 15th Annual Needham Healthcare Conference
MARIETTA, Ga., April 5, 2016 /PRNewswire/ — MiMedx Group, Inc. (MDXG), the leading regenerative medicine company utilizing human amniotic membrane and…
Read More » -
Financial
MiMedx Announces 2015 Record Results
COMPANY RECORDS REVENUE OF $187.3 MILLION, NET INCOME OF $29.4 MILLION AND EPS OF $0.28 (BASIC) AND $0.26 (DILUTED) MARIETTA,…
Read More » -
Biologics
MiMedx To Present At 34th Annual J.P. Morgan Healthcare Conference
MARIETTA, Ga., Dec. 28, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Financial
MiMedx Provides 2016 Guidance With Forecasted Revenue Growth In Excess Of 30% And Operating Earnings Growth Of 80% Or Greater
MARIETTA, Ga., Dec. 16, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected…
Read More » -
Recon
MiMedx Updates The Status Of Its More Than 5,400 U.S. Hospitals Under Contract
MARIETTA, Ga., Dec. 7, 2015 /PRNewswire/ — MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to…
Read More » -
Hospitals
Qui Tam Complaint Against MiMedx Is Fully Dismissed
MARIETTA, Ga., Oct.12, 2015 /PRNewswire/ — MiMedx Group, Inc. MDXG, +5.32%the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to…
Read More » -
Financial
MiMedx Announces Release Date For 2015 Third Quarter Earnings Conference Call
MARIETTA, Ga., Sept. 29, 2015 /PRNewswire/ — MiMedx Group, Inc. MDXG, -1.16%the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More »